A clinical trial conducted by the Barcelona Institute for Global Health (ISGlobal) found that preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy in women living with HIV. Pregnant women with HIV who were given DHA-PPQ had a significantly lower risk of developing clinical malaria throughout pregnancy and a lower risk of becoming infected. The trial was conducted with more than 600 pregnant women in Gabon and Mozambique, who received DHA-PPQ and a placebo. The researchers hope this strategy will significantly improve the health of women and their babies in sub-Saharan Africa. The study was published in The Lancet Infectious Diseases.
Source link
African women living with HIV have an effective option to prevent malaria during pregnancy, clinical trial finds
